Key facts
- It has raised $192.5M across 2 recorded rounds; the latest was PIPE ($112.5M) in Apr 2024.
- 1 institutional filer reports fund marks on Zura Bio across 5 filings.
- Zura Bio has filed 2 Form Ds with the SEC since 2023, most recently May 2024 ($112.5M sold to 19 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Zura Bio
Create free account
No card required
Funding rounds
2 roundsApr 2024PIPE$112.5M▮
Jun 2023PIPE$80.0M▮
About Zura Bio
- Industry
- Drug Discovery
PA Mark — not yet priced
Zura Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Zura Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
1 filers · latest May 20261 SEC-registered fund reported 5 fair-value marks on Zura Bio between May 2025 and May 2026. Filer-level marks and implied $/share are available to Pro members.